194 related articles for article (PubMed ID: 7480098)
1. Pharmacokinetic interactions of nifedipine and quinidine.
Hippius M; Henschel L; Sigusch H; Tepper J; Brendel E; Hoffmann A
Pharmazie; 1995 Sep; 50(9):613-6. PubMed ID: 7480098
[TBL] [Abstract][Full Text] [Related]
2. Food interaction pharmacokinetic study of cordaflex 20 mg retard filmtablet in healthy volunteers.
Balogh Nemes K; Horváth V; Grézal G; Horvai G; Hrabéczy-Páll A; Kocsi E; Drabant S; Csörgö M; Renczes G; Klebovich I
Int J Clin Pharmacol Ther; 1998 May; 36(5):263-9. PubMed ID: 9629990
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic interactions between diltiazem and quinidine.
Laganière S; Davies RF; Carignan G; Foris K; Goernert L; Carrier K; Pereira C; McGilveray I
Clin Pharmacol Ther; 1996 Sep; 60(3):255-64. PubMed ID: 8841148
[TBL] [Abstract][Full Text] [Related]
5. [Bioequivalence of nifedipine sustained-release formulations in comparison to standard preparations in solid state].
Herrmann R
Arzneimittelforschung; 1996 Jan; 46(1):28-34. PubMed ID: 8821514
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone has no clinically significant effect on nifedipine pharmacokinetics.
Harris RZ; Inglis AM; Miller AK; Thompson KA; Finnerty D; Patterson S; Jorkasky DK; Freed MI
J Clin Pharmacol; 1999 Nov; 39(11):1189-94. PubMed ID: 10579151
[TBL] [Abstract][Full Text] [Related]
7. Lack of drug-drug interaction between cerivastatin and nifedipine.
Sachse R; Brendel E; Mück W; Rohde G; Ochmann K; Horstmann R; Kuhlmann J
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):409-13. PubMed ID: 9726692
[TBL] [Abstract][Full Text] [Related]
8. Determination of nifedipine in human plasma and its use in bioequivalence study.
Guo Y; Dai J; Qian G; Guo N; Ma Z; Guo X
Int J Pharm; 2007 Aug; 341(1-2):91-6. PubMed ID: 17507190
[TBL] [Abstract][Full Text] [Related]
9. Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.
Wonnemann M; Schug B; Schmücker K; Brendel E; van Zwieten PA; Blume H
Int J Clin Pharmacol Ther; 2006 Jan; 44(1):38-48. PubMed ID: 16425970
[TBL] [Abstract][Full Text] [Related]
10. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
[TBL] [Abstract][Full Text] [Related]
11. [Comparative human pharmacokinetic studies of 20 mg nifedipine-containing Cordaflex and Adalat film coated retared tablets].
Klebovich I; Horvai G; Grézal G; Baloghné NK; Horváth V; Kocsi E; Balogh J; Cseh A; Farsang C
Acta Pharm Hung; 1996 Jan; 66(1):29-39. PubMed ID: 8714363
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
[TBL] [Abstract][Full Text] [Related]
13. Assessment of bioavailability of experimental controlled release microcapsules of nifedipine.
Mallick S; Gupta BK; Ghosal SK
Acta Pol Pharm; 2000; 57(3):175-80. PubMed ID: 11143705
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect of orlistat on the bioavailability of a single dose of nifedipine extended-release tablets (Procardia XL) in healthy volunteers.
Melia AT; Mulligan TE; Zhi J
J Clin Pharmacol; 1996 Apr; 36(4):352-5. PubMed ID: 8728349
[TBL] [Abstract][Full Text] [Related]
15. [Role of food interaction pharmacokinetic studies in drug development. Food interaction studies of theophylline and nifedipine retard and buspirone tablets].
Drabant S; Klebovich I; Gachályi B; Renczes G; Farsang C
Acta Pharm Hung; 1998 Sep; 68(5):294-306. PubMed ID: 9805816
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of (+)- and (-)-nilvadipine after oral dosing with racemic (+)-nilvadipine in man.
Tokuma Y; Fujiwara T; Noguchi H
Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):229-37. PubMed ID: 3659571
[TBL] [Abstract][Full Text] [Related]
17. Role of small intestinal cytochromes p450 in the bioavailability of oral nifedipine.
Zhang QY; Kaminsky LS; Dunbar D; Zhang J; Ding X
Drug Metab Dispos; 2007 Sep; 35(9):1617-23. PubMed ID: 17567730
[TBL] [Abstract][Full Text] [Related]
18. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H
Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741
[TBL] [Abstract][Full Text] [Related]
19. [Effects of nifedipine controlled release on blood pressure and heart rate of spontaneously hypertensive rats. Comparison with nifedipine standard and with amlodipine].
Di Filippo C; Lampa E; Forgione A; Capuano A; Rossi F; D'Amico M
Ital Heart J Suppl; 2005 May; 6(5):285-90. PubMed ID: 15934425
[TBL] [Abstract][Full Text] [Related]
20. Influence of grapefruit juice on the pharmacokinetics of a slow release nifedipine formulation.
Sigusch H; Hippius M; Henschel L; Kaufmann K; Hoffmann A
Pharmazie; 1994 Jul; 49(7):522-4. PubMed ID: 8073064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]